256 related articles for article (PubMed ID: 28360258)
1. Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: protocol for a prospective cohort study.
Sindhu KN; Cunliffe N; Peak M; Turner M; Darby A; Grassly N; Gordon M; Dube Q; Babji S; Praharaj I; Verghese V; Iturriza-Gómara M; Kang G
BMJ Open; 2017 Mar; 7(3):e016577. PubMed ID: 28360258
[TBL] [Abstract][Full Text] [Related]
2. Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants.
Parker EPK; Bronowski C; Sindhu KNC; Babji S; Benny B; Carmona-Vicente N; Chasweka N; Chinyama E; Cunliffe NA; Dube Q; Giri S; Grassly NC; Gunasekaran A; Howarth D; Immanuel S; Jere KC; Kampmann B; Lowe J; Mandolo J; Praharaj I; Rani BS; Silas S; Srinivasan VK; Turner M; Venugopal S; Verghese VP; Darby AC; Kang G; Iturriza-Gómara M
Nat Commun; 2021 Dec; 12(1):7288. PubMed ID: 34911947
[TBL] [Abstract][Full Text] [Related]
3. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
[TBL] [Abstract][Full Text] [Related]
4. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan.
Harris V; Ali A; Fuentes S; Korpela K; Kazi M; Tate J; Parashar U; Wiersinga WJ; Giaquinto C; de Weerth C; de Vos WM
Gut Microbes; 2018 Mar; 9(2):93-101. PubMed ID: 28891751
[TBL] [Abstract][Full Text] [Related]
5. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants.
Appaiahgari MB; Glass R; Singh S; Taneja S; Rongsen-Chandola T; Bhandari N; Mishra S; Vrati S
Vaccine; 2014 Feb; 32(6):651-6. PubMed ID: 24374502
[TBL] [Abstract][Full Text] [Related]
6. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
Rongsen-Chandola T; Strand TA; Goyal N; Flem E; Rathore SS; Arya A; Winje BA; Lazarus R; Shanmugasundaram E; Babji S; Sommerfelt H; Vainio K; Kang G; Bhandari N
Vaccine; 2014 Aug; 32 Suppl 1():A134-9. PubMed ID: 25091668
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
Vesikari T; Prymula R; Schuster V; Tejedor JC; Cohen R; Bouckenooghe A; Damaso S; Han HH
Pediatr Infect Dis J; 2012 May; 31(5):509-13. PubMed ID: 22228235
[TBL] [Abstract][Full Text] [Related]
8. Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants.
Church JA; Chasekwa B; Rukobo S; Govha M; Lee B; Carmolli MP; Ntozini R; Mutasa K; McNeal MM; Majo FD; Tavengwa NV; Kirkpatrick BD; Moulton LH; Humphrey JH; Prendergast AJ
Vaccine; 2020 Mar; 38(13):2870-2878. PubMed ID: 32088018
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
[TBL] [Abstract][Full Text] [Related]
10. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
[TBL] [Abstract][Full Text] [Related]
11. Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana.
Harris VC; Armah G; Fuentes S; Korpela KE; Parashar U; Victor JC; Tate J; de Weerth C; Giaquinto C; Wiersinga WJ; Lewis KD; de Vos WM
J Infect Dis; 2017 Jan; 215(1):34-41. PubMed ID: 27803175
[TBL] [Abstract][Full Text] [Related]
12. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa.
Groome MJ; Moon SS; Velasquez D; Jones S; Koen A; van Niekerk N; Jiang B; Parashar UD; Madhi SA
Bull World Health Organ; 2014 Apr; 92(4):238-45. PubMed ID: 24700991
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction.
Mwape I; Bosomprah S; Mwaba J; Mwila-Kazimbaya K; Laban NM; Chisenga CC; Sijumbila G; Simuyandi M; Chilengi R
PLoS One; 2017; 12(12):e0187761. PubMed ID: 29281659
[TBL] [Abstract][Full Text] [Related]
15. Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial.
Ali SA; Kazi AM; Cortese MM; Fleming JA; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi A
J Infect Dis; 2014 Dec; 210(11):1772-9. PubMed ID: 24939906
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
[TBL] [Abstract][Full Text] [Related]
17. In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
Kazimbaya KM; Chisenga CC; Simuyandi M; Phiri CM; Laban NM; Bosomprah S; Permar SR; Munsaka S; Chilengi R
PLoS One; 2020; 15(11):e0240714. PubMed ID: 33170860
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants.
Kompithra RZ; Paul A; Manoharan D; Babji S; Sarkar R; Mathew LG; Kang G
Vaccine; 2014 Aug; 32 Suppl 1():A129-33. PubMed ID: 25091666
[TBL] [Abstract][Full Text] [Related]
19. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Kulkarni PS; Desai S; Tewari T; Kawade A; Goyal N; Garg BS; Kumar D; Kanungo S; Kamat V; Kang G; Bavdekar A; Babji S; Juvekar S; Manna B; Dutta S; Angurana R; Dewan D; Dharmadhikari A; Zade JK; Dhere RM; Fix A; Power M; Uprety V; Parulekar V; Cho I; Chandola TR; Kedia VK; Raut A; Flores J;
Vaccine; 2017 Oct; 35(45):6228-6237. PubMed ID: 28967523
[TBL] [Abstract][Full Text] [Related]
20. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
Chen MY; Kirkwood CD; Bines J; Cowley D; Pavlic D; Lee KJ; Orsini F; Watts E; Barnes G; Danchin M
Hum Vaccin Immunother; 2017 May; 13(5):1126-1135. PubMed ID: 28059609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
